Trevi Therapeutics Inc (TRVI) Stock Price, Quote & News

Company Profile

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough i...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 304 2499

Website: www.trevitherapeutics.com

Address:

195 Church Street, 16th Floor, New Haven, United States

Chris2bucks4life Dec. 12 at 11:16 PM

$TRVI 96k ah

0 · Reply

jlcrane Dec. 12 at 8:10 PM

$TRVI I have a lot of confidence in this company and management to execute. Good has a history to draw from with these concerns. My problem has always been the lack of PR and feeding Wallstreet regular updates and news. They have an incredible indication that few even know about. Get the word out and feed the excitement.

1 · Reply

Soheil444 Dec. 12 at 8:08 PM

$TRVI they messing with us

0 · Reply

Chris2bucks4life Dec. 12 at 3:28 PM

$TRVI today proves that yesterday was probably an attack by an institution to drag the price down to get more loaded up for the long term buyout

2 · Reply

Soheil444 Dec. 12 at 2:40 PM

$TRVI common finish green today

1 · Reply

Soheil444 Dec. 11 at 7:38 PM

$TRVI https://www.marketbeat.com/instant-alerts/filing-trevi-therapeutics-inc-trvi-shares-acquired-by-vivo-capital-llc-2025-12-09/

0 · Reply

Soheil444 Dec. 11 at 7:36 PM

$TRVI https://www.marketbeat.com/instant-alerts/filing-marshall-wace-llp-has-1355-million-stock-position-in-trevi-therapeutics-inc-trvi-2025-12-11/

0 · Reply

Chris2bucks4life Dec. 11 at 7:02 PM

$TRVI huge seller out there today for sure

0 · Reply

Chris2bucks4life Dec. 11 at 3:55 PM

$TRVI there will be small dips here and there hold on and buy small on dips do not let the mms steal your shares

0 · Reply

Soheil444 Dec. 11 at 2:58 PM

$TRVI oh common dont take away our rise from yesterday

1 · Reply

Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer

Dec 3, 2025, 2:16 PM EST - 10 days ago

Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond

Nov 13, 2025, 9:21 PM EST - 4 weeks ago

Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:05 PM EST - 4 weeks ago

Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 6, 2025, 4:05 PM EST - 5 weeks ago

Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025

Nov 4, 2025, 7:30 AM EST - 5 weeks ago

Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference

Oct 8, 2025, 7:30 AM EDT - 2 months ago

Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting

Sep 18, 2025, 7:30 AM EDT - 3 months ago

Trevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025

Sep 9, 2025, 7:15 PM EDT - 3 months ago

Trevi Therapeutics, Inc. (TRVI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Aug 28, 2025, 7:30 AM EDT - 3 months ago

Trevi Therapeutics to Participate in Upcoming September Conferences

Aug 8, 2025, 1:47 PM EDT - 4 months ago

Trevi Therapeutics, Inc. (TRVI) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 4 months ago

Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Jul 31, 2025, 4:05 PM EDT - 4 months ago

Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025

Jul 29, 2025, 7:30 AM EDT - 4 months ago

Trevi Therapeutics to Participate in Upcoming August Conferences

Jul 1, 2025, 7:30 AM EDT - 5 months ago

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Jun 5, 2025, 4:30 PM EDT - 6 months ago

Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Jun 3, 2025, 10:15 PM EDT - 6 months ago

Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

Jun 2, 2025, 4:01 PM EDT - 6 months ago

Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Jun 2, 2025, 1:42 PM EDT - 6 months ago

Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients

Jun 2, 2025, 7:00 AM EDT - 6 months ago

Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

Jun 1, 2025, 4:00 PM EDT - 6 months ago

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

May 29, 2025, 7:30 AM EDT - 7 months ago

Trevi Therapeutics to Participate in Upcoming June Conferences

$Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough$

May 20, 2025, 7:00 AM EDT - 7 months ago

Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough

May 11, 2025, 4:16 AM EDT - 7 months ago

Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 7 months ago

Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates

May 1, 2025, 4:05 PM EDT - 8 months ago

Trevi Therapeutics to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 8, 2025

Apr 3, 2025, 7:30 AM EDT - 9 months ago

Trevi Therapeutics to Participate in Upcoming April Investor Conferences

Mar 18, 2025, 6:47 PM EDT - 9 months ago

Trevi Therapeutics, Inc. (TRVI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 9 months ago

Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates

Mar 11, 2025, 4:05 PM EDT - 9 months ago

Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025

Mar 10, 2025, 11:30 AM EDT - 9 months ago

Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps

$Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough$

Mar 10, 2025, 6:00 AM EDT - 9 months ago

Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough

$Trevi Therapeutics to Host Conference Call and Webcast on March 10th to Share Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough$